{"transactions":[{"id":4092450,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":170152,"kind":"person","name":"Werber Yaron","position":1,"cik":"0001704638","reported_name":"Werber Yaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, CFO, Sec. and Treas."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-23T16:47:05.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date."}],"balance_after":131000,"derivative":{"exercise_price":9.18,"expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001209191-18-004916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704638/000120919118004916/doc4.xml","form_type":"4"}},{"id":4326707,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":170152,"kind":"person","name":"Werber Yaron","position":1,"cik":"0001704638","reported_name":"Werber Yaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO, CFO, Sec. and Treas."}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-10T17:17:42.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":93022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms."}],"balance_after":93022,"derivative":{"exercise_price":8.5,"exercise_date":"2017-05-10","expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":93022},"source":{"system":"sec-edgar","filing":"0001209191-17-031377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704638/000120919117031377/doc4.xml","form_type":"4"}}]}